Skip to main content

Avanos Medical, Inc. (AVNS) Stock Forecast

Data as of Jun 16, 2026

Healthcare · Current price $24.96 (+0.02%)

Consensus Target
$23.00
Upside
-7.8%
Analysts
Rating

Price Target Range

Low $20.00Consensus $23.00High $26.00
▲ Current $24.96

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Oct 30, 2024Rick WiseStifel Nicolaus$20.00-19.9%

AVNS vs Sector & Market

MetricAVNSHealthcare AvgLarge Cap Avg
Analyst Rating2.242.41
Analyst Count819
Target Upside-7.8%+11475.0%+17.1%
P/E Ratio-16.834.0431.98

Revenue Estimates

PeriodLowAvgHigh#
2026-06-30$173M$173M$173M1
2026-09-30$181M$181M$181M1
2026-12-31$186M$186M$186M1
2027-03-31$176M$176M$176M1
2027-06-30$181M$181M$181M1
2027-09-30$189M$189M$189M1
2027-12-31$194M$194M$194M1

EPS Estimates

PeriodLowAvgHigh#
2026-06-30$0.16$0.16$0.161
2026-09-30$0.33$0.33$0.331
2026-12-31$0.37$0.37$0.371
2027-03-31$0.29$0.29$0.291
2027-06-30$0.30$0.30$0.301
2027-09-30$0.32$0.32$0.321
2027-12-31$0.34$0.34$0.341

Frequently Asked Questions

What is the analyst consensus for AVNS?

The consensus among 0 analysts covering Avanos Medical, Inc. (AVNS) is — with an average price target of $23.00.

What is the highest price target for AVNS?

The highest price target for AVNS is $20.00, set by Rick Wise at Stifel Nicolaus on 2024-10-30.

What is the lowest price target for AVNS?

The lowest price target for AVNS is $20.00, set by Rick Wise at Stifel Nicolaus on 2024-10-30.

How many analysts cover AVNS?

0 analysts have issued ratings for Avanos Medical, Inc. in the past 12 months.

Is AVNS a buy or sell right now?

Based on 0 analyst ratings, AVNS has a consensus rating of — with a -7.8% upside to the consensus target of $23.00.

What are the earnings estimates for AVNS?

Analysts estimate AVNS will report EPS of $0.16 for the period ending 2026-06-30, with revenue estimated at $173M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.